• Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $50.00 at Truist Financial

    Source: Buzz FX / 05 Mar 2025 13:11:14   America/New_York


    Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $50.00 at Truist Financial Written by MarketBeat March 5, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective lower
    Read more...
Share on,